Conventional DCs (which are CD103+) present antigen via MHCI and MHCII to CD8+ and CD4+ T-cells, to induce a tumor cytolytic response or a Th1/Th2/Th17 response respectively (138). This evidence concerns the gene CD4 and neoplasm.